461
Participants
Start Date
September 2, 2008
Primary Completion Date
December 10, 2009
Study Completion Date
December 10, 2009
SPD503-AM
SPD503 (Guanfacine Extended Release)-AM Optimized 1-4mg
SPD503-PM
SPD503 (Guanfacine Extended Release)-PM Optimized 1-4mg
Placebo
Placebo matched to Guanfacine Hydrochloride Extended Release
UCSD Department of Psychiatry, San Diego
Richmond Behavioral Associates, Staten Island
Bioscience Research, LLC, Mount Kisco
Western Psychiatric Institute and Clinic, Pittsburgh
NeuroScience, Inc, Herndon
Marc Hertzman, MD, PC, Rockville
Delmarva Family Resources, Salisbury
Psychiatric Alliance of the Blue Ridge Clinical Research, Charlottesville
Dominion Clinical Research, Midlothian
Alliance Research Group, Richmond
Bayou City Research, Richmond
Duke University Medical Center ADHD Program, Durham
Triangle Neuropsychiatry, PLLC, Durham
Peds Research Inc., Barnwell
Clinical Neuroscience Solutions, Inc., Jacksonville
Sarkis Clinical Trials, Gainesville
Florida Clinical Research Center, LLC, Bradenton
Florida Clinical Research Center, LLC, Maitland
Clinical Neuroscience Solutions, Inc., Orlando
Miami Children's Hospital, Miami
Janus Center for Psychiatric Research, West Palm Beach
Gulfcoast Clinical Research Center, Fort Myers
Harmonex Neuroscience Research, Dothan
Pedia Research, LLC, Owensboro
Department of Psychiatry, The Ohio State University, Columbus
University Hospitals Cleveland Medical Center, Cleveland
Goldpoint Clinical Research, LLC, Indianapolis
Pedia Research, Newburgh
Behavioral Medicine Center, Troy
Neurobehaviorial Medicine, Bloomfield Hills
Rochester Center for Behavioral Medicine, Rochester Hills
American Medical Research, Inc, Oak Brook
AMR-Baber Research, Inc., Naperville
Midwest Research Group/St. Charles Psychiatric Associates, Saint Charles
The Center for Pharmaceutical Research, Kansas City
Psychiatric Associates, Overland Park
Vince and Associates Clinical Research, Overland Park
Premier Psychiatric Research Inst. LLC, Lincoln
Clinical Study Centers, LLC, Little Rock
IPS Research, Oklahoma City
InSite Clinical Research, DeSoto
FutureSearch Trials, Austin
Claghorn-Lesem Research Clinic, Inc., Houston
Red Oak Psychiatry Associates, PA, Houston
Wharton Research Center, Wharton
Cerebral Research, LLC, San Antonio
Western Clinical Investigations, Lubbock
Melmed Center, Scottsdale
Centers for Psychiatry and Behavioral Medicine, Las Vegas
Peninsula Research Associates, Rolling Hills Estates
Valley Clinical Research, Inc., El Centro
Elite Clinical Trials, Inc, Wildomar
University of California, San Francisco, San Francisco
Oregon Center for Clinical Investigations, INC (OCCI, Inc.), Portland
Summit Research Network, Portland
Oregon Center for Clinical Investigations, Inc, Salem
Oregon Center for Clinical Investigations, Inc, Eugene
Northwest Clinical Research Center, Bellevue
Massachussests General Hospital, Cambridge
Children's Specialized Hospital, Toms River
Vermont Clinical Study Center, Burlington
Lead Sponsor
Shire
INDUSTRY